Related Experiment Video

Updated: Oct 1, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

[Meningococcal disease in Africa--epidemiology and prevention]

G Norheim1, E Rosenqvist, P Aavitsland

  • 1Avdeling for vaksine, Statens institutt for folkehelse, Oslo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|July 25, 2000
PubMed

Insights

Neisseria meningitidis causes widespread meningitis epidemics, particularly in Africa. Current vaccines are insufficient for young children, highlighting the need for new protein-based vaccines to induce long-term immunity.

Area of Science:

  • Microbiology
  • Epidemiology
  • Vaccinology

Background:

  • Neisseria meningitidis is a leading cause of bacterial meningitis globally, responsible for significant mortality, especially among children.
  • Epidemics of meningococcal disease, primarily caused by serogroup A, continue to impact Africa and beyond.
  • Existing polysaccharide vaccines for serogroup A lack long-term efficacy in children under two and fail to establish immunological memory.

Purpose of the Study:

  • To address the limitations of current meningococcal vaccines.
  • To emphasize the urgent need for novel vaccines against serogroup A meningococcal disease.
  • To advocate for the intensification of research into alternative protein-based vaccines.

Main Methods:

  • Review of current epidemiological data on Neisseria meningitidis outbreaks.
  • Analysis of the immunological properties and limitations of existing polysaccharide and conjugate vaccines.
  • Assessment of the potential for developing new vaccine strategies.

Main Results:

  • Serogroup A Neisseria meningitidis remains a significant threat, causing substantial global morbidity and mortality.
  • Current vaccines do not provide adequate protection for vulnerable populations, particularly young children.
  • Development of conjugate vaccines against serogroup A has faced challenges.

Conclusions:

  • There is a critical need for vaccines that induce long-term immunity across all age groups for serogroup A meningococcal disease.
  • Protein-based vaccine development requires increased focus and resources.
  • Effective vaccination strategies are essential to combat devastating meningococcal epidemics.

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...